Content about Israel

May 2, 2013
Study calculates optimal upper limit of vitamin D

Researchers claim to have calculated for the first time the upper safe limit of vitamin D levels of 36 nanograms per milliliter, above which the associated risk for cardiovascular events or death raises significantly, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

CHEVY CHASE, Md. — Researchers claim to have calculated for the first time the upper safe limit of vitamin D levels of 36 nanograms per milliliter, above which the associated risk for cardiovascular events or death raises significantly, according to a recent study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

January 8, 2013
Mobile app increased medication adherence to 81%, developer says

The makers of a new app say that it increased users' medication adherence rate to more than 80%.

HAIFA, Israel — The makers of a new app say that it increased users' medication adherence rate to more than 80%.

The MediSafe Project said Tuesday that users reported medication adherence rates of 81%, while the rate was 84.25% for patients using statins.

December 11, 2012
SISU Entertainment launches 'Shalom Sesame' DVD club

The award-winning "Shalom Sesame" DVD series is now available as part of a year-long DVD club, SISU Entertainment announced.

NEW YORK — The award-winning "Shalom Sesame" DVD series is now available as part of a year-long DVD club designed to provide consumers a wide array of discount purchasing plans to meet their specific needs, SISU Entertainment announced today.

August 27, 2012
Delhaize Group selects in-store software provider

Delhaize Group has enlisted the services of Retalix for in-store software for Delhaize Group's 3,300 locations — including more than 20,000 point-of-sale terminals — across Eurasia and the United States.

RA'ANANA, Israel — Delhaize Group has enlisted the services of Retalix for in-store software for Delhaize Group's 3,300 locations — including more than 20,000 point-of-sale terminals — across Eurasia and the United States.

March 6, 2012
SodaStream introduces new flavors sweetened with stevia

SodaStream has launched a new line of flavors sweetened with an all-natural plant-based sweetener.

AIRPORT CITY, Israel — SodaStream has launched a new line of flavors sweetened with an all-natural plant-based sweetener.

SodaStream said its stevia-laden flavors initially will launch in Europe, with U.S. sales expected to begin this summer. The initial flavors, with less than five calories per serving, include pink grapefruit, peach-pear, orange, lemon-lime, cranberry-apple and others.

January 17, 2012
Taro committee continues to evaluate Sun offer, Taro says

A committee formed by Taro Pharmaceutical Industries in December is continuing to evaluate an acquisition offer by India-based Sun Pharmaceutical Industries, Taro said.

HAIFA BAY, Israel — A committee formed by Taro Pharmaceutical Industries in December is continuing to evaluate an acquisition offer by India-based Sun Pharmaceutical Industries, Taro said.

Sun is hoping to acquire Israel-based Taro for $24.50 per share.

The committee, comprising members of the company's board of directors, has brought on Citigroup Global Markets as its financial adviser and is receiving legal advice from Israeli legal firm Goldfarb Seligman & Co. and U.S. firm Willkie Farr & Gallagher.

December 6, 2011
Taro forms special committee to review Sun offer

Israel's Taro Pharmaceutical Industries has formed a special committee to review an offer by India's Sun Pharmaceutical Industries for all of the issues of Taro that Sun doesn't already own, Taro said.

HAIFA BAY, Israel — Israel's Taro Pharmaceutical Industries has formed a special committee to review an offer by India's Sun Pharmaceutical Industries for all of the shares of Taro that it doesn't already own, Taro said.

Sun offered Taro $24.50 per share on Oct. 18. Sun has sought to acquire Taro since 2008.

Taro reported a 14.2% increase in sales in second quarter 2011 over second quarter 2010, while profits increased by $19.3 million during the same period.

June 1, 2011
XTL granted orphan drug designation for multiple myeloma treatment

The Food and Drug Administration has given orphan drug designation to an investigational treatment for multiple myeloma, a blood cell cancer, that soon will enter mid-stage development.

HERZLIYA, Israel — The Food and Drug Administration has given orphan drug designation to an investigational treatment for multiple myeloma, a blood cell cancer, that soon will enter mid-stage development.

XTL announced that the FDA had granted the designation to its recombinant human erythropoietin, or rHuEPO drug, for which the company soon will start phase-2 clinical trials.

The FDA gives orphan drug designation to treatments for diseases that affect fewer than 200,000 people in the United States per year.

February 25, 2011
Protalix receives CRL for Gaucher disease treatment

The Food and Drug Administration has declined to approve a biologic treatment for a rare genetic disorder by Israeli drug maker Protalix Biotherapeutics, Protalix said Friday.

KARMIEL, Israel — The Food and Drug Administration has declined to approve a biologic treatment for a rare genetic disorder by Israeli drug maker Protalix Biotherapeutics, Protalix said Friday.

The company said the FDA issued a complete response letter for its application for taliglucerase alfa, a treatment for Gaucher disease. The FDA issues a CRL when it has finished reviewing a regulatory application, but questions remain that preclude final approval.

October 6, 2010
Gestational diabetes test may predict Type 2 diabetes among women

A new Tel Aviv University study found a test used to diagnose gestational diabetes in...

TEL AVIV, Israel A new Tel Aviv University study found a test used to diagnose gestational diabetes in women could be a key indicator to diagnosing Type 2 diabetes.

September 16, 2010
Drug-resistant bacterial infections reported in 20 states, worldwide

Drug-resistant bacterial infections recently have been reported in more than 20 states across the United...